Study: No Proof of Epilepsy Drug Suicide Risk
Study Finds No Evidence of Increased Risk for Suicide Attempts or Suicides Associated With Seizure Drugs in Patients With Epilepsy
WebMD News Archive
Aug. 4, 2010 -- Drugs used by epilepsy patients to control seizures now carry a warning that the medications may increase the risk for suicide, but a newly published analysis involving more than 5 million people finds no evidence of such a risk.
The study is the latest to challenge a 2008 research review by the FDA that linked many commonly prescribed epilepsy drugs to an increase in suicidal thoughts and behaviors.
Researchers examined data collected from patients treated with seizure medications for epilepsy, depression, or bipolar disorder in the U.K. during a 20-year period ending in 2008.
Suicide Risk Higher in Epilepsy Patients
As previously reported, patients with any of the three conditions had a higher risk for suicide, compared to the general population.
But no increase in risk associated with treatment was seen among patients with a diagnosis of epilepsy alone.
The research appears in the Aug. 5 issue of the New England Journal of Medicine.
Massachusetts-based drugmaker Sepracor Inc. funded the study. The company is seeking FDA approval for its seizure drug Stedesa.
“Even in patients with epilepsy and depression, the risk was low,” lead researcher Alejandro Arana, MD, of the drug safety research group Pharmacovigilance Services, tells WebMD. “We did not find any increase in risk associated with use of anti-epileptic drugs by patients with epilepsy.”
Unlike many previous studies, the researchers were able to individually assess risk among different groups of patients treated with seizure drugs, including those with epilepsy, depression, or bipolar disorder alone and patients with epilepsy and depression or epilepsy and bipolar disorder.
Certain seizure drugs are used for the treatment of depression and bipolar disorder, in addition to epilepsy.
Neurologist and epilepsy researcher Josemir W. Sander, MD, of the University College London, says the assessment of risk in different subtypes of patients is a major strength of the study.
Specific Drugs Not Examined
An increase in suicide risk associated with treatment was found in patients with depression alone and in patients with an unknown diagnosis without epilepsy, depression, or bipolar disorder.
Researchers were not able to assess risk associated with specific seizure medications. Several recently reported studies have been contradictory.